Effect of Dapagliflozin on Glycemic Variability as an add-on Therapy in Subjects With Type 2 Diabetes Mellitus With in Inadequate Glycemic Control in Insulin: a Multicenter, Placebo-controlled, Double-blind, Randomized Study
Phase of Trial: Phase IV
Latest Information Update: 17 Jul 2017
At a glance
- Drugs Dapagliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms DIVE
- 12 Jul 2017 Status changed from recruiting to completed.
- 10 Jun 2017 Biomarkers information updated
- 27 Apr 2016 Planned End Date changed from 1 Aug 2016 to 1 Nov 2016.